Solid Biosciences Inc. (SLDB) Form 8-K Material Events
Solid Biosciences Inc. (SLDB) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SLDB
CIK: 1707502
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerThomas Feeley
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-10-02 | 4 | 0001193125-26-415649 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-14 | — | SCHEDULE 13D/A Filing | 0001193125-26-352656 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003502 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338438 | View SEC Doc Filr Page |
| 424B5 | 2026-08-06 | — | 424B5 | 0001193125-26-338410 | View SEC Doc Filr Page |
| S-3ASR | 2026-08-06 | — | S-3ASR | 0001193125-26-338387 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-337935 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002128 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0002012383-26-003093 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | 4 | 0001193125-26-297456 | View SEC Doc Filr Page |
| 3 | 2026-06-24 | 2026-06-22 | 3 Filing | 0001231919-26-000697 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-24 | — | SCHEDULE 13D/A Filing | 0001346824-26-000183 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267504 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267503 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267502 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267501 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267500 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267499 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267496 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267494 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267489 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-10 | 8-K | 0001193125-26-265804 | View SEC Doc Filr Page |
| 424B7 | 2026-06-05 | — | 424B7 | 0001193125-26-259503 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-219337 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-05 | — | SCHEDULE 13G/A Filing | 0002005369-26-000031 | View SEC Doc Filr Page |